Gilead/ News/ News/ Oncology Gilead develops solid tumour cell therapy with Gadeta Richard Staines CAR T, Gadeta, Gilead, Kite, R&D, TCRs 0 Comment Gilead has option to buy biotech if things go well Share X Gilead develops solid tumour cell therapy with Gadeta https://pharmaphorum.com/news/gilead-develops-solid-tumour-cell-therapy-with-gadeta/
News/ R&D/ UK & Europe Immunocore and GSK pick third cancer immunotherapy target Andrew McConaghie GSK, immuno-oncology, Immunocore, TCRs 0 Comment Immunocore, one of UK biotech’s brightest hopes, has selected a third target as part of its immuno-oncology partnership Share X Immunocore and GSK pick third cancer immunotherapy target https://pharmaphorum.com/news/immunocore-gsk-pick-third-cancer-immunotherapy-target/